Daniel Bulut

829 total citations
27 papers, 682 citations indexed

About

Daniel Bulut is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Daniel Bulut has authored 27 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Cardiology and Cardiovascular Medicine and 7 papers in Oncology. Recurrent topics in Daniel Bulut's work include Cell death mechanisms and regulation (6 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). Daniel Bulut is often cited by papers focused on Cell death mechanisms and regulation (6 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers) and Angiogenesis and VEGF in Cancer (3 papers). Daniel Bulut collaborates with scholars based in Germany and Türkiye. Daniel Bulut's co-authors include Andreas Mügge, Christoph Hanefeld, Jan Börgel, Vanessa Becker, Ansgar M. Chromik, Waldemar Uhl, Jörg T. Epplen, Martin Spiecker, H. Neubauer and Adrien Daigeler and has published in prestigious journals such as European Journal of Pharmacology, BMC Medicine and Journal of Hypertension.

In The Last Decade

Daniel Bulut

26 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Bulut Germany 17 226 208 116 93 92 27 682
Hesong Zeng China 16 275 1.2× 157 0.8× 84 0.7× 97 1.0× 91 1.0× 38 732
Seung Hee Lee South Korea 10 294 1.3× 99 0.5× 110 0.9× 62 0.7× 72 0.8× 19 832
Sven‐Christian Pawelzik Sweden 18 254 1.1× 114 0.5× 101 0.9× 76 0.8× 97 1.1× 26 954
Masaki Imanishi Japan 17 249 1.1× 121 0.6× 106 0.9× 99 1.1× 86 0.9× 64 934
Soumaya Ben‐Aicha Spain 14 208 0.9× 176 0.8× 186 1.6× 55 0.6× 100 1.1× 37 711
Theo Nell South Africa 17 223 1.0× 71 0.3× 78 0.7× 100 1.1× 112 1.2× 32 783
Paola Songia Italy 18 145 0.6× 359 1.7× 126 1.1× 38 0.4× 56 0.6× 40 719
Manasi S. Shah United States 7 402 1.8× 165 0.8× 137 1.2× 127 1.4× 43 0.5× 8 873
Houshang Monajemi Netherlands 16 273 1.2× 119 0.6× 133 1.1× 195 2.1× 48 0.5× 26 883
Shi Tai China 17 214 0.9× 202 1.0× 180 1.6× 59 0.6× 54 0.6× 53 837

Countries citing papers authored by Daniel Bulut

Since Specialization
Citations

This map shows the geographic impact of Daniel Bulut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Bulut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Bulut more than expected).

Fields of papers citing papers by Daniel Bulut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Bulut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Bulut. The network helps show where Daniel Bulut may publish in the future.

Co-authorship network of co-authors of Daniel Bulut

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Bulut. A scholar is included among the top collaborators of Daniel Bulut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Bulut. Daniel Bulut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bulut, Daniel, et al.. (2013). Red Wine Ingestion Prevents Microparticle Formation After a Single High-Fat Meal—A Crossover Study in Healthy Humans. Journal of Cardiovascular Pharmacology. 61(6). 489–494. 14 indexed citations
2.
Harati, Kamran, Ansgar M. Chromik, Daniel Bulut, et al.. (2013). Effects of TRAIL and taurolidine on apoptosis and proliferation in human rhabdomyosarcoma, leiomyosarcoma and epithelioid cell sarcoma. International Journal of Oncology. 42(3). 945–956. 10 indexed citations
3.
4.
Schneider, Jochen, Ansgar M. Chromik, Waldemar Uhl, Andreas Mügge, & Daniel Bulut. (2011). Apoptosis in esophagus and pancreas carcinoma cells induced by circulating microparticles is related to phosphatidyl serine and microparticle-associated caspases. Medical Oncology. 29(2). 962–969. 9 indexed citations
5.
Chromik, Ansgar M., Stephan A. Hahn, Adrien Daigeler, et al.. (2010). Gene expression analysis of cell death induction by Taurolidine in different malignant cell lines. BMC Cancer. 10(1). 595–595. 10 indexed citations
6.
Chromik, Ansgar M., Adrien Daigeler, Daniel Bulut, et al.. (2010). Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines. Journal of Experimental & Clinical Cancer Research. 29(1). 21–21. 23 indexed citations
7.
Bulut, Daniel, et al.. (2010). Effect of protein A immunoadsorption on T cell activation in patients with inflammatory dilated cardiomyopathy. Clinical Research in Cardiology. 99(10). 633–638. 26 indexed citations
8.
Börgel, Jan, Stephanie Springer, Hans‐Werner Duchna, et al.. (2010). Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co-prevalence. Clinical Research in Cardiology. 99(8). 499–506. 31 indexed citations
9.
Neubauer, H., et al.. (2009). Comparing the antiplatelet effect of clopidogrel hydrogensulfate and clopidogrel besylate: a crossover study. Clinical Research in Cardiology. 98(9). 533–540. 27 indexed citations
10.
Börgel, Jan, Daniel Bulut, Christoph Hanefeld, et al.. (2008). The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile. BMC Cardiovascular Disorders. 8(1). 41–41. 32 indexed citations
11.
Daigeler, Adrien, Daniel Bulut, Marcus Lehnhardt, et al.. (2008). TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma. Journal of Experimental & Clinical Cancer Research. 27(1). 82–82. 26 indexed citations
12.
Bulut, Daniel, et al.. (2008). Circulating Endothelial Microparticles Correlate Inversely With Endothelial Function in Patients With Ischemic Left Ventricular Dysfunction. Journal of Cardiac Failure. 14(4). 336–340. 54 indexed citations
13.
Bulut, Daniel, et al.. (2008). CD31+/Annexin V+ microparticles in healthy offsprings of patients with coronary artery disease. European Journal of Clinical Investigation. 39(1). 17–22. 37 indexed citations
14.
Börgel, Jan, Stefan Wieczorek, Nikolaus Büchner, et al.. (2007). Risk factors and myocardial infarction in patients with obstructive sleep apnea: impact of β2-adrenergic receptor polymorphisms. BMC Medicine. 5(1). 1–1. 71 indexed citations
15.
Chromik, Ansgar M., Adrien Daigeler, Daniel Bulut, et al.. (2007). Synergistic Effects in Apoptosis Induction by Taurolidine and TRAIL in HCT-15 Colon Carcinoma Cells. Journal of Investigative Surgery. 20(6). 339–348. 16 indexed citations
16.
Bulut, Kerem, Peter Felderbauer, Juris J. Meier, et al.. (2007). Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts. European Journal of Pharmacology. 578(2-3). 279–285. 34 indexed citations
17.
18.
Hanefeld, Christoph, et al.. (2005). Comparison of Endothelial Function in Patients with Metabolic Syndrome on Bezafibrate or Atorvastatin Therapy. Cardiovascular Drugs and Therapy. 19(2). 153–155. 1 indexed citations
19.
Bulut, Daniel, et al.. (2003). Selective cyclo-oxygenase-2 inhibition with parecoxib acutely impairs endothelium-dependent vasodilatation in patients with essential hypertension. Journal of Hypertension. 21(9). 1663–1667. 56 indexed citations
20.
Bulut, Daniel, et al.. (2003). Impaired vasodilator responses to atrial natriuretic peptide in essential hypertension. European Journal of Clinical Investigation. 33(7). 567–573. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hesong Zeng Breakdown of academic impact, for papers by Seung Hee Lee Breakdown of academic impact, for papers by Sven‐Christian Pawelzik Breakdown of academic impact, for papers by Masaki Imanishi Breakdown of academic impact, for papers by Soumaya Ben‐Aicha Breakdown of academic impact, for papers by Theo Nell Breakdown of academic impact, for papers by Paola Songia Breakdown of academic impact, for papers by Manasi S. Shah Breakdown of academic impact, for papers by Houshang Monajemi Breakdown of academic impact, for papers by Shi Tai
Rankless by CCL
2026